The results suggested that BTN3A1 may have a role in shaping the immunosuppressive tumor microenvironment and may sever as a tumor suppressor in breast cancer and NSCLC by promoting the invasion of innate and adaptive immune cells and inhibition of the invasion of MDSCs. The gene discussed is BTN3A1; the disease is breast cancer.